Request Discount

Urinary Tract Infection Market (Drug Class - Quinolones, Aminoglycosides, β-lactam, Azoles, and Other Drug Class; Clinical Indications - Cystitis, Urethritis, Pyelonephritis, and Other Clinical Indications; End User - Hospitals, Self-administered, and Other End Users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : July, 2019

  • Rep Id : HC0590

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Urinary Tract Infection Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Urinary Tract Infection Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Urinary Tract Infection Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on the urinary tract infection market provides an in-depth analysis of segments and sub-segments in the global as well as regional urinary tract infection market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional urinary tract infection market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global urinary tract infection market. According to the report, the global urinary tract infection market is projected to grow at a CAGR of 3.5% over the forecast period of 2019-2025.

Market Insight

Urinary tract infection (UTI) can occur in any part of the urinary system such as kidneys, ureters, bladder, and urethra. The intensity of the infection observed more in the lower urinary tract that is bladder and urethra. Around 150 million people get affected by Urinary tract infection each year, Urinary tract infection is prominent in women, around 60 percent compared to men.

Increasing the prevalence of Urinary tract infection (UTI) globally is the major factor driving the market. It is estimated around 150 million people get affected with Urinary tract infection every year. The prevalence of the UTI marked a significant growth in a decade. Moreover, rising hospital-borne infections and growing geriatric population also fuelling the growth of the market. Furthermore increasing antibiotic resistance in bacteria is also causing to swell the urinary tract infection cases. On the other hand, unmet clinical requirements, and increasing market fragmentation can hamper the growth of the market. However rising awareness about women health provides better opportunities to the market.

Geographically, the urinary tract infection market segmented by North America, Europe, Asia Pacific, and RoW. Among these North America is anticipated to stay at the top position in the global market. Rising prevalence of urinary tract infection especially because of diseases such as diabetes, high rate of diagnosis, and increasing awareness about urinary tract infection are such factors contributing to the growth of the market in this region. Europe holds the second position in the global urinary tract infection market owing to the availability of the advanced healthcare facilities, and higher hospitalization rate. The market in Asia-Pacific is estimated to grow with a lucrative rate in the forecast period. Rising prevalence of urinary tract infection, presence of large patient pools suffering from diabetes especially in countries like India and China and raising awareness about urinary tract infection, especially in women will augment the growth of the market in the forecast period.

Urinary Tract Infection Market

Segment Covered

The report on the global urinary tract infection market covers segments such as drug class, clinical indications, and end user. On the basis of drug class, the sub-markets include quinolones, aminoglycosides, β-lactam, azoles, and other drug class. On the basis of clinical indications, the sub-markets include cystitis, urethritis, pyelonephritis, and other clinical indications. On the basis of end user, the sub-markets include hospitals, self-administered, and other end users. 

Companies Profiled:

The report provides profiles of the companies in the market such as Merck & Co., Inc., Bayer AG, Johnson & Johnson, Novartis AG, Allergan plc, AstraZeneca plc, Mylan N.V., Novo Nordisk A/S, Sun Pharmaceuticals ltd., and Other companies. 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the urinary tract infection market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount